SEARCH

SEARCH BY CITATION

References

  • 1
    Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr 1991 Genetic determinations of bone mass in adult women: A reevaluation of twin model and the potential importance of gene interaction on heritability estimates J Bone Miner Res 6:561567.
  • 2
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Ebert S 1987 Genetic determinants of bone mass in adults: A twin study J Clin Invest 80:706710.
  • 3
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles Nature 367:284287.
  • 4
    Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H 1995 Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis Biochem Biophys Res Commun 217:378383.
  • 5
    Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene J Bone Miner Res 11:306311.
  • 6
    Weisgraber KH, Rall SC Jr, Mahley RW 1981 Human E apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of apo E isoforms J Biol Chem 256:90779083.
  • 7
    Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families Science 261:921923.
  • 8
    Laakso M, Kesaniemi A, Kervinen K, Jauhiainen M, Pyorala K 1991 Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes Br Med J 303:11591162.
  • 9
    Saupe J, Shearer MJ, Kahlmeier M 1993 Phylloquinone transport and its influence on γ-χαλβoζψγλνταματε residues of osteocalcin in patients on maintenance hemodyalysis Am J Clin Nutr 58:204208.
  • 10
    Hosoda K, Eguchi H, Nakamoto T, Kubota T, Honda H, Jindai S, Hasegawa R, Kiyoki M, Yamaji T, Shiraki M 1992 Sandwich immunoassay for intact human osteocalcin Clin Chem 38:22332238.
  • 11
    Eguchi H, Hosoda K, Kurihara N, Nakamoto T, Kobayashi S, Arita M, Hasegawa R, Ohta T, Kiyoki M, Yamaji T, Shiraki M 1995 Sandwich immunoassay specific for the N-terminal sequence of osteocalcin J Immunol Meth 184:231240.
  • 12
    Brown RC, Aston JP, Weeks I, Woodhead JS 1987 Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay J Clin Endocrinol Metab 65:407414.
  • 13
    Ishizuka S, Naruchi T, Hashimoto Y, Orimo H 1981 Radioreceptor assay for 1 alpha 24(R), 25 trihydroxyvitamin D in human serum J Nutr Sci Vitaminol 27:7179.
  • 14
    Ubelhart D, Gineyts E, Chapuy MC, Delmas PD 1990 Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease Bone Miner 8:8796.
  • 15
    Kataoka S, Paidi M, Howard BV 1994 Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype Clin Chem 40:1113.
  • 16
    Kamboh MI, Ferrell RE, Kottke B 1988 Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism J Lipid Res 29:15351543.
  • 17
    Eto M, Watanabe K, Ishii K 1986 A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations Clin Genet 30:422427.
  • 18
    Sing CF, Davignon J 1985 Role of the apolipprotein E polymorphism in determining normal plasma lipid and lipoprotein variation Am J Hum Genet 37:268285.
  • 19
    Shiraki M, Shiraki Y, Aoki C, Eguchi H 1995 Genotypes of vitamin D receptor gene and response to vitamin D3 treatment in postmenopausal osteoporosis J Bone Miner Res 10(Suppl 1):S187.
  • 20
    Johansen J, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: An indicator of spontaneous bone loss and the effect of estrogen treatment in postmenopausal women Eur J Clin Invest 18:191195.
  • 21
    Ubelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links J Clin Endocrinol Metab 72:367373.
  • 22
    Davignon J, Gregg RE, Sing CF 1988 Apolipoprotein E polymorphism and atherosclerosis Arteriosclerosis 8:121.
  • 23
    Weisgraber KH, Innerarity TL, Mahley RW 1982 Abnormal lipoprotein receptor-binding activity of human E apolipoprotein due to cysteine-arginine interchange at a single site J Biol Chem 257:25182521.
  • 24
    Hara K, Akiyama Y, Tajima T, Shiraki M 1993 Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro J Bone Miner Res 8:535542.
  • 25
    Hara K, Akiyama Y, Nakamura T, Murota S, Morita I 1995 The inhibitory effect of vitamin K2 (Menatetrenone) on bone resorption may be related to its side chain Bone 16:179184.
  • 26
    Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD 1991 Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women J Bone Miner Res 6:12111216.
  • 27
    Hart JP, Shearer MJ, Klenerman L, Catterall A, Reeve J, Sambrook PN, Dodds RA, Bitensky L, Chayen J 1985 Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis J Clin Endocrinol Metab 60:12681269.
  • 28
    Basu SK, Ho Y, Brown MS, Bilheimer DW, Anderson GW, Goldstein J 1982 Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes J Biol Chem 257:97889795.
  • 29
    Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE 1994 Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro Science 264:850852.
  • 30
    Mahley RW 1988 Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology Science 240:622630.